Literature DB >> 26990358

Role of microRNAs in primary central nervous system lymphomas.

Xin Yu1, Zheng Li2, Jianxiong Shen2, Matthew T V Chan3, William Ka Kei Wu3,4.   

Abstract

Primary central nervous system lymphomas (PCNSL) are extranodal non-Hodgkin lymphomas arising exclusively inside the CNS, and account for about 3% of primary intracranial tumours. This tumour lacks systemic manifestations and prognosis of patients with PCNSL remains poor despite recent advancement of chemoradiotherapy. MicroRNAs are small non-coding RNAs that post-transcriptionally downregulate gene expression by binding to target mRNAs, inducing their degradation or translational repression. MicroRNAs play significant roles in almost all malignancy-related biological processes, including cell proliferation, differentiation, apoptosis and metabolism. Many deregulated miRNAs has been identified in PCNSL but their biological significance remains to be fully elucidated. In this review, we summarize current evidence regarding the pathogenic role of PCNSL-associated microRNAs and their potential applications for diagnosis and prognostication of this deadly disease.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26990358      PMCID: PMC6495944          DOI: 10.1111/cpr.12243

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  65 in total

1.  Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.

Authors:  Xuhua Mao; Yuan Sun; Junming Tang
Journal:  Neurol Sci       Date:  2013-07-06       Impact factor: 3.307

2.  Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas.

Authors:  Jinfeng Zheng; Jiagang Xu; Shufang Ma; Xiyan Sun; Ming Geng; Lin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

Review 3.  Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Authors:  Khê Hoang-Xuan; Eric Bessell; Jacoline Bromberg; Andreas F Hottinger; Matthias Preusser; Roberta Rudà; Uwe Schlegel; Tali Siegal; Carole Soussain; Ufuk Abacioglu; Nathalie Cassoux; Martina Deckert; Clemens M F Dirven; Andrés J M Ferreri; Francesc Graus; Roger Henriksson; Ulrich Herrlinger; Martin Taphoorn; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2015-07       Impact factor: 41.316

Review 4.  Posttransplant lymphoproliferative disorder of the central nervous system.

Authors:  Christian Kempf; Marianne Tinguely; Elisabeth J Rushing
Journal:  Pathobiology       Date:  2013-08-30       Impact factor: 4.342

5.  Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Alexander Baraniskin; Jan Kuhnhenn; Uwe Schlegel; Andrew Chan; Martina Deckert; Ralf Gold; Abdelouahid Maghnouj; Hannah Zöllner; Anke Reinacher-Schick; Wolff Schmiegel; Stephan A Hahn; Roland Schroers
Journal:  Blood       Date:  2011-01-03       Impact factor: 22.113

6.  Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.

Authors:  Jianjian Gao; Qingyun Zhang; Jianjun Xu; Lijuan Guo; Xuefeng Li
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

7.  Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.

Authors:  Jan-Lukas Robertus; Geert Harms; Tjasso Blokzijl; Marije Booman; Daphne de Jong; Gustaaf van Imhoff; Stefano Rosati; Ed Schuuring; Philip Kluin; Anke van den Berg
Journal:  Mod Pathol       Date:  2009-03-13       Impact factor: 7.842

8.  DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.

Authors:  Zheng Li; Huizi Lei; Min Luo; Yi Wang; Lei Dong; Yanni Ma; Changzheng Liu; Wei Song; Fang Wang; Junwu Zhang; Jianxiong Shen; Jia Yu
Journal:  Gastric Cancer       Date:  2014-01-31       Impact factor: 7.701

9.  MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

Authors:  Li-Juan Wang; Chen-Chen He; Xin Sui; Meng-Jiao Cai; Cong-Ya Zhou; Jin-Lu Ma; Lei Wu; Hao Wang; Su-Xia Han; Qing Zhu
Journal:  Oncotarget       Date:  2015-03-20

Review 10.  MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Priscilla T Y Law; Matthew T V Chan; William K K Wu
Journal:  Oncotarget       Date:  2015-06-10
View more
  8 in total

1.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

2.  The molecular basis of brain injury in preterm infants with sepsis - associated encephalopathy.

Authors:  Xiaohui Gong; Bowen Weng; Xiaoyue Zhang; Chongbing Yan; Cheng Cai
Journal:  BMC Pediatr       Date:  2022-06-10       Impact factor: 2.567

3.  Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.

Authors:  Akio Kimura; Masao Takemura; Ginette Serrero; Nobuaki Yoshikura; Yuichi Hayashi; Kuniaki Saito; Takashi Inuzuka
Journal:  J Neurooncol       Date:  2018-01-16       Impact factor: 4.130

4.  Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.

Authors:  Franziska S Thaler; Sarah A Laurent; Marion Huber; Matthias Mulazzani; Martin Dreyling; Uwe Ködel; Tania Kümpfel; Andreas Straube; Edgar Meinl; Louisa von Baumgarten
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

5.  MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.

Authors:  Yuanyuan Wang; Jingmei Cao; Shiyun Zhang; Lei Sun; Yi Nan; Hong Yao; Jian Fan; Li Ying Zhu; Lei Yu
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

6.  APRIL and BAFF: novel biomarkers for central nervous system lymphoma.

Authors:  Matthias Mulazzani; Marion Huber; Sabine Borchard; Sigrid Langer; Barbara Angele; Elisabeth Schuh; Edgar Meinl; Martin Dreyling; Tobias Birnbaum; Andreas Straube; Uwe Koedel; Louisa von Baumgarten
Journal:  J Hematol Oncol       Date:  2019-10-15       Impact factor: 17.388

7.  Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).

Authors:  Yanxia Liu; Qingmin Yao; Feng Zhang
Journal:  Int J Oncol       Date:  2021-02-01       Impact factor: 5.650

8.  High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.

Authors:  Shun Wang; Zhenkuan Xu; Chao Zhang; Rui Yu; Jun Jiang; Chengwei Wang; Chuncheng Qu
Journal:  Biomed Res Int       Date:  2020-10-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.